Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Phenomix Investigational Site 105, Montgomery

Phenomix Investigational Site 121, Tempe

Phenomix Investigational Site 137, Tempe

Phenomix Investigational Site 105, Anaheim

Phenomix Investigational Site 103, Long Beach

Phenomix Investigational Site 106, Los Angeles

Phenomix Investigational Site 143, Coral Gables

Phenomix Investigational Site 142, Hialeah

Phenomix Investigational Site 133, Kissimmee

Phenomix Investigational Site 101, Honolulu

Phenomix Investigational Site 135, Chicago

Phenomix Investigational Site 124, Indianapolis

Phenomix Investigational Site 136, Brockton

Phenomix Investigational Site 138, Biloxi

Phenomix Investigational Site 122, Las Vegas

Phenomix Investigational Site 140, Las Vegas

Phenomix Investigational Site 110, Trenton

Phenomix Investigational Site 116, Albuquerque

Phenomix Investigational Site 107, Winston-Salem

Phenomix Investigational Site 112, Greenville

Phenomix Investigational Site 102, Dallas

Phenomix Investigational Site 104, San Antonio

Phenomix Investigational Site 100, Kenosha

Phenomix Investigational Site 402, Buenos Aires

Phenomix Investigational Site 408, Buenos Aires

Phenomix Investigational Site 410, Mendoza

Phenomix Investigational Site 208, Prague

Phenomix Investigational Site 209, Praha 4 Chodov

Phenomix Investigational Site 207, Uničov

Phenomix Investigational Site 707, Shāstrinagar

Phenomix Investigational Site 701, Bangalore

Phenomix Investigational Site 705, Trivandrum

Phenomix Investigational Site 706, Indore

Phenomix Investigational Site 711, Mumbai

Phenomix Investigational Site 607, Arequipa

Phenomix Investigational Site 601, Ica

Phenomix Investigational Site 604, Lima

Phenomix Investigational Site 610, Lima

Phenomix Investigational Site 300, Gdansk

Phenomix Investigational Site 309, Karkow

Phenomix Investigational Site 303, Katowice

Phenomix Investigational Site 306, Puławy

Phenomix Investigational Site 305, Warsaw

Phenomix Investigational Site 302, Wroclaw